SARS‐CoV‐2 pandemic in the Brazilian community of rare diseases: A patient reported survey

…, DDG Horovitz, MVMB Wilke… - American Journal of …, 2021 - Wiley Online Library
The COVID‐19 pandemic has led to a reorganization of health systems to prioritize the fight
against the virus. The adoption of social distancing interfered with the flow of existing policies…

[HTML][HTML] Follow-up of pre-motor symptoms of Parkinson's disease in adult patients with Gaucher disease type 1 and analysis of their lysosomal enzyme profiles in the …

MVMB Wilke, F Poswar, WV Borelli… - Orphanet Journal of …, 2023 - Springer
Background Parkinson’s disease (PD) is the second most common neurodegenerative
disease worldwide. Its classic motor symptoms may be preceded by non-motor symptoms (NMS). …

Mucopolysaccharidosis: caregiver quality of life

NR Guarany, AP Vanz, MVMB Wilke… - Journal of Inborn …, 2015 - journals.sagepub.com
The mucopolysaccharidoses (MPSs) are a group of rare genetic diseases caused by a
deficiency of specific enzymes involved in catabolism of glycosaminoglycans, which causes …

Expanding the phenotype of DNAJC30‐associated Leigh syndrome

…, M Krygier, M Pawłowicz, MVMB Wilke… - Clinical …, 2022 - Wiley Online Library
Leigh syndrome (LS) is a progressive neurodegenerative disease, characterized by extensive
clinical, biochemical, and genetic heterogeneity. Recently, biallelic variants in DNAJC30 …

[HTML][HTML] A Brazilian Rare-Disease Center's Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG …

M Vernet Machado Bressan Wilke, GD Iop… - International Journal of …, 2024 - mdpi.com
Gaucher disease (GD, OMIM 230800) is one of the most common lysosomal disorders, being
caused by the deficient activity of the enzyme acid β-glucocerebrosidase (Gcase). Three …

[HTML][HTML] A Broad Characterization of Glycogen Storage Disease IV Patients: A Clinical, Genetic, and Histopathological Study

MVMB Wilke, BM de Oliveira, RT Starosta, M Shinawi… - Biomedicines, 2023 - mdpi.com
Glycogen storage disease type IV (GSD IV) is an ultra-rare autosomal recessive disease
caused by variants in the GBE1 gene, which encodes the glycogen branching enzyme (GBE). …

MARK2 variants cause autism spectrum disorder via the downregulation of WNT/β-catenin signaling pathway

M Gong, J Li, Y Liu, VMBW Matheus, Q Li, H Liu… - medRxiv, 2024 - medrxiv.org
MARK2, a member of the evolutionarily conserved PAR1/MARK serine/threonine kinase
family, has been identified as a novel risk gene for autism spectrum disorder (ASD) based on …

CARDIOMYOPATHY-RELATED GENETIC VARIANTS AND THEIR PHENOTYPES: A GENOTYPE-FIRST APPROACH

M Figueiral, A Paldino, MVMB Wilke, J Farris… - Journal of the American …, 2024 - jacc.org
Background Cardiomyopathies constitute the leading cause of heart failure. Identification of
genetic risk preemptively may allow detection of the earliest phenotypic manifestations …

Avaliação da qualidade de vida em jovens adultos com Doença de Gaucher tipo 1

MVMB Wilke, FP Vairo, CBO Netto - Revista HCPA. Porto Alegre, 2013 - lume.ufrgs.br
Introdução: A doença de gaucher (DG) é a doença de depósito lisossomal mais freqüente e
é causada pela deficiência na atividade da enzima B-glicocerebrosidase e pelo acúmulo …

Evolução dos sintomas não motores da doença de Parkinson em uma coorte de pacientes com doença de Gaucher tipo 1

MVMB Wilke - 2022 - lume.ufrgs.br
CONTEXTO: A doença de Gaucher (DG) é um erro inato do metabolismo causado pela
atividade deficiente da enzima beta-glucocerebrosidase (GCase), que catalisa a conversão de …